Ong is also an executive director of Aoxin Q&M.
Dr Ong Siew Hwa, the CEO of Acumen Diagnostics, has been placed on a leave of absence by the company’s board of directors. Acumen is a subsidiary of Mainboard-listed Q&M Dental Group (SGX:QC7
) and an associated company of Catalist-listed Aoxin Q&M (SGX:1D4) Dental Group.
The move was made to facilitate investigations into Ong’s acquisition of an indirect interest in the assets of a supplier of Acumen as well as the ancillary issues arising from the acquisition.
